Digest Network Come funziona
Network
/
Società
Sk
Non verificato

Skyhawk Therapeutics

Di cosa scriviamo

FarmaceuticaFitnessMedicina - VarieSaluteSanità

5 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
01/06/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
Fonte
Skyhawk Therapeutics
Emittente
PR News Wire
1.00
0
10/03/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease
Fonte
Skyhawk Therapeutics
Emittente
PR News Wire
1.00
0
Press Release cover image
02/03/2026
Salute
Fitness
Medicina - Varie
Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Fonte
Skyhawk Therapeutics
Emittente
PR News Wire
1.00
0
15/03/2025
Farmaceutica
Sanità
Biologia
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025
Fonte
Skyhawk Therapeutics
Emittente
PR News Wire
1.00
0
Press Release cover image
25/06/2024
Farmaceutica
Sanità
Biologia
Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel, Switzerland Location
Fonte
Skyhawk Therapeutics
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0